Clinical trials
Learning clinical trials
Below are recruiting learning clinical trials, each written for real people, not researchers. We’re tracking 595 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05800821Recruiting
Predicting brain blood-flow problems after carotid surgery
This study uses deep learning to predict which people are at risk for “cerebral hyperperfusion syndrome” (a dangerous spike in brain blood flow) after carotid revascularization. If you qualify, they’ll use scans/tests to estimate your risk so doctors can watch you more closely if needed.
MinskAges 30–80 - NCT05864157Recruiting
Targeted training to improve walking in Parkinson’s disease
This study tests a targeted motor training approach to improve walking (gait) in people with Parkinson’s disease. You may be considered if your walking is affected but you can already walk steadily for 10 minutes without help.
Chapel Hill, North CarolinaAges 50–80 - NCT05864976Recruiting
MRI planning help for people with suspected brain tumor
This trial uses a special MRI approach and computer analysis to help plan neurosurgery for adults with a brain lesion that looks like glioblastoma. It may improve how surgeons find and navigate the target area before an operation.
St Louis, MissouriAges 18 years+ - NCT05828511RecruitingPhase 1/Phase 2
Study drug for newly diagnosed myeloma before standard treatment
This trial tests linvoseltamab (a new targeted immune treatment) to see if it’s safe and how well it works in adults with recently diagnosed multiple myeloma who haven’t started treatment yet. Because it’s a “window of opportunity” study, it’s meant to learn early results before standard therapy is fully underway.
Los Angeles, CaliforniaAges 18 years+ - NCT05832177Recruiting
Spanish and English outreach training and feedback program
This program tests outreach “training” activities (like online training, podcasts, and stakeholder sessions) and asks participants to complete modules and evaluations. It may help improve cancer education and community engagement efforts.
Tampa, FloridaAges 18 years+ - NCT05825014Recruiting
Using computer prediction to reduce COPD complications
This study uses information from past hospital discharge records and breathing test results to predict who with COPD may have worse health outcomes later. It may help future COPD care by identifying higher-risk patients earlier.
Hong Kong, New TerritoriesAges 40 years+ - NCT05833555Recruiting
Harlem Strong mental health support for adults
This program is for Black and Latino adults in Harlem who are dealing with mild to moderate depression symptoms. It aims to identify people who may benefit from mental health support and connect them with the right level of care.
New York, New YorkAges 18–65 - NCT05806112Enrolling by invitation
Improve staff well-being programs for residential care workers
This trial tests whether specific programs can reduce burnout and improve resiliency (coping strength) among staff who work in behavioral health group homes. It may help workers feel better and handle stressful work days.
Boston, MassachusettsAges 18 years+ - NCT05789953Recruiting
Machine-learning plan to prevent lung complications after surgery
This trial tests a computer-based (machine-learning) approach to help prevent lung problems after elective surgery done under general anesthesia. It may help by identifying higher-risk patients and guiding care to reduce postoperative pulmonary complications.
UlmAges 18 years+ - NCT05789758Recruiting
Study of Spinraza in pregnancy for 5q spinal muscular atrophy
This study looks at how Spinraza (nusinersen) taken during or before pregnancy affects people with 5q spinal muscular atrophy (SMA) and the health of their babies. It mainly fits those who were pregnant and received Spinraza around the time of conception or during pregnancy.
Palo Alto, CaliforniaAges 18–54 - NCT05317390Recruiting
Tests an AI tool to diagnose isolated dystonia
This trial checks whether an AI (software) called DystoniaNet can accurately identify isolated dystonia using information from your evaluation, and compares its results to standard diagnosis. If you have focal, segmental, or generalized dystonia, this study may help improve faster and more accurate diagnosis in the future.
Boston, MassachusettsAges Any age - NCT05748171RecruitingPhase 2
Testing inotuzumab for children with early ALL relapse
This Phase 2 study tests inotuzumab ozogamicin (InO), a cancer medicine, in children aged 1 to under 18 with a first relapse of ALL. It aims to find out how well and safely the medicine works when the leukemia comes back early.
ViennaAges 1–17 - NCT05760846Recruiting
Training hand skills after a recent stroke
This study looks at a therapy that helps people with a recent stroke relearn coordinated hand and arm movements. It compares how well motor skill learning works and may help improve functional use of the affected arm.
Yvoir, NamurAges 18–90 - NCT05730036RecruitingPhase 3
Linvoseltamab vs standard treatment for relapsed myeloma
This trial compares linvoseltamab against a standard combination (elotuzumab + pomalidomide + dexamethasone) in adults with multiple myeloma that has returned or not responded. It aims to find out whether linvoseltamab works better and is safe for people who have already had some myeloma treatments.
Los Angeles, CaliforniaAges 18 years+ - NCT05733104Recruiting
Study of Zavicefta safety after it’s used in Korea
This study looks at how the antibiotic Zavicefta is doing after it’s been approved and used by doctors in Korea. It may help confirm its safety and appropriate use for certain serious infections.
Seoul, Gangnam-guAges 3 months+ - NCT05736302Recruiting
Check an activity-tracking algorithm against a body-weight test
This trial checks whether a new computer algorithm that uses an accelerometer (movement sensor) can accurately estimate your body’s activity and energy use. It compares the phone/wearable movement data to results from a special way of measuring how your body uses energy.
Milwaukee, WisconsinAges 18 years+ - NCT05739331Recruiting
AI-assisted breathing test to check swollen chest lymph nodes
This trial uses an AI-supported breathing procedure to help doctors examine enlarged lymph nodes in the chest when the cause is still unknown. It may help improve how accurately and efficiently doctors assess these lymph nodes so you can get answers sooner.
LevangerAges 18 years+ - NCT05702645Recruiting
Down syndrome long-term study after leukemia treatment
This study follows children and young adults with Down syndrome who have survived acute leukemia (ALL or AML) to learn about their longer-term health after treatment ends. It may help families and doctors understand what health problems to watch for and how to provide better follow-up care.
Birmingham, AlabamaAges 6–39 - NCT05701852Recruiting
Study brain scans during tasks in chronic nerve pain
This study looks at how brain activity changes in people with long-lasting nerve pain using an MRI scan while you do simple behavioral tasks. It may help researchers understand brain function in chronic neuropathic pain and how it affects day-to-day abilities.
ParisAges 18 years+ - NCT05707806Recruiting
Brain and decision tasks to study learning
This study tests how people learn from choices and make decisions using computer tasks. Some participants also complete brain scans (MRI) to see how the brain activity matches behavior.
Baltimore, MarylandAges 18–45 - NCT05677971RecruitingPhase 3
Tested medicine to treat liver scarring in PiZZ alpha-1 disease
This Phase 3 study tests fazirsiran for safety and whether it can help people with a specific genetic form of alpha-1 antitrypsin–related liver disease that causes liver scarring. You may be eligible if you have the PiZZ genetic type and moderate-to-severe fibrosis, with certain lung and liver conditions ruled out.
Birmingham, AlabamaAges 18–75 - NCT05689151Recruiting
Abrocitinib for adult moderate to severe atopic eczema
This study tests how well abrocitinib (a prescription medicine) works for adults with moderate to severe atopic dermatitis (atopic eczema). You may join if you meet the study’s health and consent requirements and your doctor believes abrocitinib is an appropriate option for you.
Amiens, SommeAges 18 years+ - NCT05707923Recruiting
Simplified language study for comprehension in autistic toddlers
This study looks at whether using simpler language helps young children with autism understand and learn. It involves children ages 1 to 4 who mainly hear and respond to English.
East Lansing, MichiganAges 1–4 - NCT05666518Recruiting
Study of vericiguat safety in Japanese chronic heart failure patients
This study checks how safe the medicine vericiguat is for Japanese people with chronic heart failure when used in everyday care. It compares patients who receive vericiguat with patients who continue standard treatments without vericiguat.
Multiple Locations, Many LocationsAges Any age
Hear when a new Learning trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for learning?
- Yes. Clin2 currently lists 595 recruiting learning studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a learning trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a learning trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.